Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07107841 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description expanded, about 66 wordsv5
  2. Eligibility criteria expanded, about 59 wordsv4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Start date changed from estimate of Sep 15, 2025 to Oct 16, 2025
    • Site details revised
    • Study description expanded, about 3 words
    • Study title expanded, about 2 words
  4. Study description expanded, about 1 wordv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
(SINGLE SITE Study) The purpose of this clinical trial is to evaluate the safety and efficacy of the use of an autologous hair follicle derived secretome for androgenous alopecia. The secretome will be injected into the scalp at baseline, and days 30, 90, 180, 270 and 365. Hair growth will be quantitatively measured for density and thickness. PROs will also be collected from participants. This study will be run at a SINGLE SITE.
Trial Details
NCT Number NCT07107841
Lead Sponsor Acorn Biolabs Inc.
Conditions
(from sponsor)		 Androgenic Alopecia, Alopecia, Baldness
Related terms Alopecia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov